Garfield Alastair
- SEC CIK
- 0002027261
In the past year, 1 open-market sale filing worth $912.7K and no purchases.
Current role at each company
- RYTM Rhythm Pharmaceuticals, Inc.Chief Scientific Officeras of Aug 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $912.7K
- 1 filing
- Net
- −$912.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Garfield Alastair as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 (view filing)5:57 PM ET | Aug 13 | 4 days | Garfield AlastairChief Scientific Officer | SSale | −7.76K | $117.57 | −$912.7K | −77.2%2.29K after | 4 lots10b5-1 |
| Jul 3, 2025 (view filing) | Jul 2 | 1 day | Garfield AlastairChief Scientific Officer | SSale | −1.32K | $64.81 | −$85.5K | −29.7%3.13K after | 2 lots10b5-1 |